vimarsana.com

Page 7 - Recursion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recursion Publishes Second Annual Environmental, Social and Governance Report

Salt Lake City, March 28, 2023 Recursion , a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced the release of its second. | March 28, 2023

Salt lake cityUnited statesChris gibsonMorningstar sustainalyticsRecursion pharmaceuticalsUnited nations sustainable development goals un sdgsGlobenewswire incExchange commissionInstitutional shareholder servicesChief executive officerShareholder servicesPrime ratingAccounting standards boardUnited nations sustainable development goalsLake cityFrancisco bay

Recursion to Participate in Upcoming Investor Conference

/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its.

Salt lake cityUnited statesGlobal biopharma conferenceSan francisco bay

Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset During First R&D Day

/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, announced the public.

Salt lake cityUnited statesChris gibsonBen mabeyCompound intelligenceChief technology officerChief executive officerDownload daySan francisco bay

Recursion to Participate in Upcoming Investor Conferences

/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its.

Salt lake cityUnited statesHealthcare conferenceAnnual needham growth conferenceSan francisco bay

RECURSION PHARMACEUTICALS, INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition. On November 8, 2022, Recursion Pharmaceuticals, Inc. issued a press release announcing its results of operations and financial condition for. | November 8, 2022

Recursion pharmaceuticals incExhibit number descriptionSecurities exchangeSecurities exchange actSecurities actExchange actExhibit numberRecursion pharmaceuticalsPage interactive data fileEdgar onlineNc stock exchangePress releaseOndition rxrx us75629v1044

vimarsana © 2020. All Rights Reserved.